GENESYS™
Delivery Platform



Pegylated Lipid
DOPC
Orion Lipopeptide
Cholesterol
The Orion GENESYS™ Platform
The GENESYS™ Delivery Platform incorporates bioinspired lipopeptides, while entirely excluding ionizable cationic lipids, for effective RNA therapy delivery

Bio-inspired Design
Drawing inspiration from natural biological processes, our lipopeptide technology enhances cellular uptake and targeting

Enhanced Cellular Uptake
We utilize optimized lipopeptide formulations that improve the efficiency of cellular entry, ensuring high uptake rates of RNA

Reduced Immunogenicity
Carefully engineered components lower the potential for immune activation as compared to ionizable LNPs, promoting safer clinical profiles

Targeted Delivery
Our precise targeting allows for direct delivery to specific cell types, minimizing off-target effects and maximizing therapeutic efficacy

Scalable Production
We incorporate state-of-the-art microfluidic technologies that guarantee consistent nanoparticle quality and scalability

Intellectual Property Protection
Our patent portfolio covers lipopeptide-based compositions, formulation processes and targeted delivery